Year |
Citation |
Score |
Low-probability matches (unlikely to be authored by this person) |
1983 |
Patriarca PA, Onorato IM, Sklar VE, Schonberger LB, Kaminski RM, Hatch MH, Morens DM, Forster RK. Acute hemorrhagic conjunctivitis Investigation of a large-scale community outbreak in Dade County, Florida. Jama. 249: 1283-9. PMID 6827704 DOI: 10.1001/jama.249.10.1283 |
0.292 |
|
2006 |
Stafford JD, Reinecke KJ, Kaminski RM, Gerard PD. Multi-stage sampling for large scale natural resources surveys: a case study of rice and waterfowl. Journal of Environmental Management. 78: 353-61. PMID 16154682 DOI: 10.1016/j.jenvman.2005.04.029 |
0.182 |
|
2012 |
Mazzuferi M, Kumar G, Rospo C, Kaminski RM. Rapid epileptogenesis in the mouse pilocarpine model: video-EEG, pharmacokinetic and histopathological characterization. Experimental Neurology. 238: 156-67. PMID 22960187 DOI: 10.1016/j.expneurol.2012.08.022 |
0.163 |
|
1983 |
Rogers MF, Morens DM, Stewart JA, Kaminski RM, Spira TJ, Feorino PM, Larsen SA, Francis DP, Wilson M, Kaufman L. National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 2. Laboratory results. Annals of Internal Medicine. 99: 151-8. PMID 6309049 |
0.16 |
|
1985 |
Onorato IM, Morens DM, Schonberger LB, Hatch MH, Kaminski RM, Turner JP. Acute hemorrhagic conjunctivitis caused by enterovirus type 70: an epidemic in American Samoa. The American Journal of Tropical Medicine and Hygiene. 34: 984-91. PMID 2994502 |
0.158 |
|
2016 |
Tomaciello F, Leclercq K, Kaminski RM. Resveratrol lacks protective activity against acute seizures in mouse models. Neuroscience Letters. PMID 27600732 DOI: 10.1016/j.neulet.2016.09.002 |
0.154 |
|
1982 |
Stansfield SK, Scribner CL, Kaminski RM, Cairns T, McCormick JB, Johnson KM. Antibody to Ebola virus in guinea pigs: Tandala, Zaire. The Journal of Infectious Diseases. 146: 483-6. PMID 6750007 DOI: 10.1093/infdis/146.4.483 |
0.154 |
|
2019 |
Auvin S, Avbersek A, Bast T, Chiron C, Guerrini R, Kaminski RM, Lagae L, Muglia P, Cross JH. Drug Development for Rare Paediatric Epilepsies: Current State and Future Directions. Drugs. PMID 31734883 DOI: 10.1007/s40265-019-01223-9 |
0.145 |
|
2017 |
Zhang Y, Vanmeert M, Siekierska A, Ny A, John J, Callewaert G, Lescrinier E, Dehaen W, de Witte PAM, Kaminski RM. Inhibition of glutamate decarboxylase (GAD) by ethyl ketopentenoate (EKP) induces treatment-resistant epileptic seizures in zebrafish. Scientific Reports. 7: 7195. PMID 28775328 DOI: 10.1038/s41598-017-06294-w |
0.145 |
|
2021 |
Lovisari F, Roncon P, Soukoupova M, Paolone G, Labasque M, Ingusci S, Falcicchia C, Marino P, Johnson M, Rossetti T, Petretto E, Leclercq K, Kaminski RM, Moyon B, Webster Z, et al. Implication of sestrin3 in epilepsy and its comorbidities. Brain Communications. 3: fcaa130. PMID 33758823 DOI: 10.1093/braincomms/fcaa130 |
0.142 |
|
2019 |
Leclercq K, Matagne A, Provins L, Klitgaard H, Kaminski RM. Pharmacological profile of the antiepileptic drug candidate padsevonil - characterization in rodent seizure and epilepsy models. The Journal of Pharmacology and Experimental Therapeutics. PMID 31619464 DOI: 10.1124/jpet.119.261222 |
0.141 |
|
2022 |
Abram M, Jakubiec M, Reeb K, Cheng MH, Gedschold R, Rapacz A, Mogilski S, Socała K, Nieoczym D, Szafarz M, Latacz G, Szulczyk B, Kalinowska-Tłuścik J, Gawel K, Esguerra CV, et al. Discovery of ()--Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity . Journal of Medicinal Chemistry. PMID 35984707 DOI: 10.1021/acs.jmedchem.2c00534 |
0.135 |
|
2014 |
Leclercq K, Matagne A, Kaminski RM. Low potency and limited efficacy of antiepileptic drugs in the mouse 6 Hz corneal kindling model. Epilepsy Research. 108: 675-83. PMID 24661426 DOI: 10.1016/j.eplepsyres.2014.02.013 |
0.133 |
|
2015 |
Leclercq K, Afrikanova T, Langlois M, De Prins A, Buenafe OE, Rospo CC, Van Eeckhaut A, de Witte PA, Crawford AD, Smolders I, Esguerra CV, Kaminski RM. Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafish. Epilepsy & Behavior : E&B. 45: 53-63. PMID 25845493 DOI: 10.1016/j.yebeh.2015.03.019 |
0.13 |
|
2011 |
Kaminski RM, Fu Z, Venkatesan K, Mazzuferi M, Leclercq K, Seutin V, Vicini S. 11-Deoxycortisol impedes GABAergic neurotransmission and induces drug-resistant status epilepticus in mice. Neuropharmacology. 60: 1098-108. PMID 20883706 DOI: 10.1016/J.Neuropharm.2010.09.021 |
0.13 |
|
2018 |
Frigerio F, Pasqualini G, Craparotta I, Marchini S, van Vliet EA, Foerch P, Vandenplas C, Leclercq K, Aronica E, Porcu L, Pistorius K, Colas RA, Hansen TV, Perretti M, Kaminski RM, et al. n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis. Brain : a Journal of Neurology. PMID 30307467 DOI: 10.1093/brain/awy247 |
0.13 |
|
2022 |
Zhang Y, Heylen L, Partoens M, Mills JD, Kaminski RM, Godard P, Gillard M, de Witte PAM, Siekierska A. Connectivity Mapping Using a Novel Loss-of-Function Zebrafish Epilepsy Model as a Powerful Strategy for Anti-epileptic Drug Discovery. Frontiers in Molecular Neuroscience. 15: 881933. PMID 35686059 DOI: 10.3389/fnmol.2022.881933 |
0.129 |
|
2024 |
Socała K, Jakubiec M, Abram M, Mlost J, Starowicz K, Kamiński RM, Ciepiela K, Andres-Mach M, Zagaja M, Metcalf CS, Zawadzki P, Wlaź P, Kamiński K. TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates. Progress in Neurobiology. 240: 102634. PMID 38834133 DOI: 10.1016/j.pneurobio.2024.102634 |
0.128 |
|
2004 |
Kaminski RM, Tochman AM, Dekundy A, Turski WA, Czuczwar SJ. Ethosuximide and valproate display high efficacy against lindane-induced seizures in mice. Toxicology Letters. 154: 55-60. PMID 15475178 DOI: 10.1016/j.toxlet.2004.07.002 |
0.128 |
|
2016 |
Klitgaard H, Matagne A, Nicolas JM, Gillard M, Lamberty Y, De Ryck M, Kaminski RM, Leclercq K, Niespodziany I, Wolff C, Wood M, Hannestad J, Kervyn S, Kenda B. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment. Epilepsia. 57: 538-48. PMID 26920914 DOI: 10.1111/epi.13340 |
0.127 |
|
2008 |
Kaminski RM, Matagne A, Leclercq K, Gillard M, Michel P, Kenda B, Talaga P, Klitgaard H. SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy. Neuropharmacology. 54: 715-20. PMID 18207204 DOI: 10.1016/j.neuropharm.2007.11.021 |
0.125 |
|
2004 |
Kaminski RM, Banerjee M, Rogawski MA. Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist. Neuropharmacology. 46: 1097-104. PMID 15111016 DOI: 10.1016/j.neuropharm.2004.02.010 |
0.121 |
|
2019 |
Leclercq K, Liefferinge JV, Albertini G, Neveux M, Dardenne S, Mairet-Coello G, Vandenplas C, Deprez T, Chong SA, Foerch P, Bentea E, Sato H, Maher P, Massie A, Smolders I, ... Kaminski RM, et al. Anticonvulsant and antiepileptogenic effects of system inactivation in chronic epilepsy models. Epilepsia. PMID 31179549 DOI: 10.1111/epi.16055 |
0.12 |
|
2014 |
Fritsch B, Reis J, Gasior M, Kaminski RM, Rogawski MA. Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 5765-75. PMID 24760837 DOI: 10.1523/Jneurosci.5307-13.2014 |
0.12 |
|
2016 |
Delahaye-Duriez A, Srivastava P, Shkura K, Langley SR, Laaniste L, Moreno-Moral A, Danis B, Mazzuferi M, Foerch P, Gazina EV, Richards K, Petrou S, Kaminski RM, Petretto E, Johnson MR. Rare and common epilepsies converge on a shared gene regulatory network providing opportunities for novel antiepileptic drug discovery. Genome Biology. 17: 245. PMID 27955713 DOI: 10.1186/s13059-016-1097-7 |
0.119 |
|
2018 |
Srivastava PK, Eyll JV, Godard P, Mazzuferi M, Delahaye-Duriez A, Steenwinckel JV, Gressens P, Danis B, Vandenplas C, Foerch P, Leclercq K, Mairet-Coello G, Cardenas A, Vanclef F, Laaniste L, ... ... Kaminski RM, et al. A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target. Nature Communications. 9: 3561. PMID 30177815 DOI: 10.1038/s41467-018-06008-4 |
0.119 |
|
2009 |
Kaminski RM, Matagne A, Patsalos PN, Klitgaard H. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam. Epilepsia. 50: 387-97. PMID 18627416 DOI: 10.1111/j.1528-1167.2008.01713.x |
0.119 |
|
2012 |
Barkmeier DT, Senador D, Leclercq K, Pai D, Hua J, Boutros NN, Kaminski RM, Loeb JA. Electrical, molecular and behavioral effects of interictal spiking in the rat. Neurobiology of Disease. 47: 92-101. PMID 22472188 DOI: 10.1016/J.Nbd.2012.03.026 |
0.119 |
|
2017 |
Klein P, Dingledine R, Aronica E, Bernard C, Blümcke I, Boison D, Brodie MJ, Brooks-Kayal AR, Engel J, Forcelli PA, Hirsch LJ, Kaminski RM, Klitgaard H, Kobow K, Lowenstein DH, et al. Commonalities in epileptogenic processes from different acute brain insults: Do they translate? Epilepsia. PMID 29247482 DOI: 10.1111/Epi.13965 |
0.117 |
|
2024 |
Jakubiec M, Abram M, Zagaja M, Socała K, Panic V, Latacz G, Mogilski S, Szafarz M, Szala-Rycaj J, Saunders J, West PJ, Nieoczym D, Przejczowska-Pomierny K, Szulczyk B, Krupa A, et al. Discovery and Profiling of New Multimodal Phenylglycinamide Derivatives as Potent Antiseizure and Antinociceptive Drug Candidates. Acs Chemical Neuroscience. PMID 39166702 DOI: 10.1021/acschemneuro.4c00438 |
0.114 |
|
2020 |
Kamiński K, Mogilski S, Abram M, Rapacz A, Latacz G, Szulczyk B, Walczak M, Kuś K, Matyjaszczyk K, Kamiński RM. KA-104, a new multitargeted anticonvulsant with potent antinociceptive activity in preclinical models. Epilepsia. PMID 32929733 DOI: 10.1111/epi.16669 |
0.114 |
|
2015 |
Leclercq K, Kaminski RM. Genetic background of mice strongly influences treatment resistance in the 6 Hz seizure model. Epilepsia. 56: 310-8. PMID 25524462 DOI: 10.1111/epi.12893 |
0.114 |
|
2003 |
Kaminski RM, Gasior M, Carter RB, Witkin JM. Protective efficacy of neuroactive steroids against cocaine kindled-seizures in mice. European Journal of Pharmacology. 474: 217-22. PMID 12921865 DOI: 10.1016/S0014-2999(03)02086-7 |
0.114 |
|
1982 |
Patriarca PA, Rogers MF, Morens DM, Schonberger LB, Kaminski RM, Burns JC, Glode MP. Kawasaki syndrome: association with the application of rug shampoo. Lancet. 2: 578-80. PMID 6125730 DOI: 10.1016/S0140-6736(82)90660-2 |
0.113 |
|
2019 |
Johnson MR, Kaminski RM. A systems-level framework for anti-epilepsy drug discovery. Neuropharmacology. 107868. PMID 31785261 DOI: 10.1016/j.neuropharm.2019.107868 |
0.113 |
|
2014 |
Kaminski RM, Rogawski MA, Klitgaard H. The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 385-400. PMID 24671870 DOI: 10.1007/s13311-014-0266-1 |
0.112 |
|
2013 |
Mazzuferi M, Kumar G, van Eyll J, Danis B, Foerch P, Kaminski RM. Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy. Annals of Neurology. 74: 560-8. PMID 23686862 DOI: 10.1002/ana.23940 |
0.111 |
|
2017 |
Aronica E, Bauer S, Bozzi Y, Caleo M, Dingledine R, Gorter JA, Henshall DC, Kaufer D, Koh S, Löscher W, Louboutin JP, Mishto M, Norwood BA, Palma E, Poulter MO, ... ... Kaminski RM, et al. Neuroinflammatory targets and treatments for epilepsy validated in experimental models. Epilepsia. 58: 27-38. PMID 28675563 DOI: 10.1111/Epi.13783 |
0.111 |
|
2024 |
Jakubiec M, Abram M, Zagaja M, Andres-Mach M, Szala-Rycaj J, Latacz G, Honkisz-Orzechowska E, Mogilski S, Kubacka M, Szafarz M, Pociecha K, Przejczowska-Pomierny K, Wyska E, Socała K, Nieoczym D, et al. Novel Alaninamide Derivatives with Drug-like Potential for Development as Antiseizure and Antinociceptive Therapies─In Vitro and In Vivo Characterization. Acs Chemical Neuroscience. PMID 38741575 DOI: 10.1021/acschemneuro.4c00013 |
0.111 |
|
2020 |
Muglia P, Hannestad J, Brandt C, DeBruyn S, Germani M, Lacroix B, Majoie M, Otoul C, Sciberras D, Steinhoff BJ, Van Laere K, Van Paesschen W, Webster E, Kaminski RM, Werhahn KJ, et al. Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach. Brain Communications. 2: fcaa183. PMID 33241213 DOI: 10.1093/braincomms/fcaa183 |
0.11 |
|
2014 |
Crèvecoeur J, Kaminski RM, Rogister B, Foerch P, Vandenplas C, Neveux M, Mazzuferi M, Kroonen J, Poulet C, Martin D, Sadzot B, Rikir E, Klitgaard H, Moonen G, Deprez M. Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis. Neuropathology and Applied Neurobiology. 40: 191-204. PMID 23617838 DOI: 10.1111/Nan.12054 |
0.109 |
|
2015 |
Kretschmann A, Danis B, Andonovic L, Abnaof K, van Rikxoort M, Siegel F, Mazzuferi M, Godard P, Hanon E, Fröhlich H, Kaminski RM, Foerch P, Pfeifer A. Different microRNA profiles in chronic epilepsy versus acute seizure mouse models. Journal of Molecular Neuroscience : Mn. 55: 466-79. PMID 25078263 DOI: 10.1007/s12031-014-0368-6 |
0.105 |
|
2016 |
Löscher W, Gillard M, Sands ZA, Kaminski RM, Klitgaard H. Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond. Cns Drugs. PMID 27752944 DOI: 10.1007/s40263-016-0384-x |
0.105 |
|
2020 |
Abram M, Rapacz A, Mogilski S, Latacz G, Lubelska A, Kamiński RM, Kamiński K. Multitargeted Compounds Derived from (2,5-Dioxopyrrolidin-1-yl)(phenyl)-Acetamides as Candidates for Effective Anticonvulsant and Antinociceptive Agents. Acs Chemical Neuroscience. PMID 32479058 DOI: 10.1021/acschemneuro.0c00257 |
0.105 |
|
2017 |
Srivastava PK, Bagnati M, Delahaye-Duriez A, Ko JH, Rotival M, Langley SR, Shkura K, Mazzuferi M, Danis B, van Eyll J, Foerch P, Behmoaras J, Kaminski RM, Petretto E, Johnson MR. Genome-wide analysis of differential RNA editing in epilepsy. Genome Research. 27: 440-450. PMID 28250018 DOI: 10.1101/gr.210740.116 |
0.105 |
|
2005 |
Kaminski RM, Shippenberg TS, Witkin JM, Rocha BA. Genetic deletion of the norepinephrine transporter decreases vulnerability to seizures. Neuroscience Letters. 382: 51-5. PMID 15911120 DOI: 10.1016/J.Neulet.2005.02.056 |
0.104 |
|
2007 |
Dekundy A, Kaminski RM, Zielinska E, Turski WA. NMDA antagonists exert distinct effects in experimental organophosphate or carbamate poisoning in mice. Toxicology and Applied Pharmacology. 219: 114-21. PMID 17157343 DOI: 10.1016/j.taap.2006.10.030 |
0.104 |
|
2009 |
Kaminski RM, Gillard M, Leclercq K, Hanon E, Lorent G, Dassesse D, Matagne A, Klitgaard H. Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam. Epilepsia. 50: 1729-40. PMID 19486357 DOI: 10.1111/j.1528-1167.2009.02089.x |
0.103 |
|
2024 |
Kamiński K, Socała K, Abram M, Jakubiec M, Reeb KL, Temmermand R, Zagaja M, Maj M, Kolasa M, Faron-Górecka A, Andres-Mach M, Szewczyk A, Hameed MQ, Fontana ACK, Rotenberg A, et al. Enhancement of Glutamate Uptake as Novel Antiseizure Approach: Preclinical Proof of Concept. Annals of Neurology. PMID 39512205 DOI: 10.1002/ana.27124 |
0.103 |
|
2004 |
Kaminski RM, Livingood MR, Rogawski MA. Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia. 45: 864-7. PMID 15230714 DOI: 10.1111/j.0013-9580.2004.04504.x |
0.102 |
|
2021 |
Abram M, Jakubiec M, Rapacz A, Mogilski S, Latacz G, Szulczyk B, Szafarz M, Socała K, Nieoczym D, Wyska E, Wlaź P, Kamiński RM, Kamiński K. Identification of New Compounds with Anticonvulsant and Antinociceptive Properties in a Group of 3-substituted (2,5-dioxo-pyrrolidin-1-yl)(phenyl)-Acetamides. International Journal of Molecular Sciences. 22. PMID 34884898 DOI: 10.3390/ijms222313092 |
0.101 |
|
2003 |
Dekundy A, Kaminski RM, Turski WA. Dizocilpine improves beneficial effects of cholinergic antagonists in anticholinesterase-treated mice. Toxicological Sciences : An Official Journal of the Society of Toxicology. 72: 289-95. PMID 12660363 DOI: 10.1093/toxsci/kfg013 |
0.1 |
|
2024 |
Klein P, Kaminski RM, Koepp M, Löscher W. New epilepsy therapies in development. Nature Reviews. Drug Discovery. PMID 39039153 DOI: 10.1038/s41573-024-00981-w |
0.097 |
|
2020 |
Klein P, Friedman A, Hameed MQ, Kaminski RM, Bar-Klein G, Klitgaard H, Koepp M, Jozwiak S, Prince DA, Rotenberg A, Twyman R, Vezzani A, Wong M, Löscher W. Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy? Epilepsia. 61: 359-386. PMID 32196665 DOI: 10.1111/Epi.16450 |
0.096 |
|
2015 |
Leclercq K, Kaminski RM. Status epilepticus induction has prolonged effects on the efficacy of antiepileptic drugs in the 6-Hz seizure model. Epilepsy & Behavior : E&B. 49: 55-60. PMID 26123104 DOI: 10.1016/j.yebeh.2015.06.011 |
0.094 |
|
2007 |
Kaminski RM, Blaszczak P, Dekundy A, Parada-Turska J, Calderazzo L, Cavalheiro EA, Turski WA. Lithium-methomyl induced seizures in rats: a new model of status epilepticus? Toxicology and Applied Pharmacology. 219: 122-7. PMID 17092527 DOI: 10.1016/j.taap.2006.09.017 |
0.094 |
|
2007 |
Kaminski RM, Witkin JM, Shippenberg TS. Pharmacological and genetic manipulation of kappa opioid receptors: effects on cocaine- and pentylenetetrazol-induced convulsions and seizure kindling. Neuropharmacology. 52: 895-903. PMID 17126860 DOI: 10.1016/J.Neuropharm.2006.10.007 |
0.093 |
|
2020 |
Abram M, Jakubiec M, Rapacz A, Mogilski S, Latacz G, Kamiński RM, Kamiński K. The Search for New Anticonvulsants in a Group of (2,5-Dioxopyrrolidin-1-yl)(phenyl)Acetamides with Hybrid Structure-Synthesis and In Vivo/In Vitro Studies. International Journal of Molecular Sciences. 21. PMID 33233618 DOI: 10.3390/ijms21228780 |
0.09 |
|
2022 |
Jakubiec M, Abram M, Zagaja M, Andres-Mach M, Szewczyk A, Latacz G, Szulczyk B, Socała K, Nieoczym D, Wlaź P, Metcalf CS, Wilcox K, Kamiński RM, Kamiński K. New Phenylglycinamide Derivatives with Hybrid Structure as Candidates for New Broad-Spectrum Anticonvulsants. Cells. 11. PMID 35740990 DOI: 10.3390/cells11121862 |
0.089 |
|
2023 |
Mahmud M, Wade C, Jawad S, Hadi Z, Otoul C, Kaminski RM, Muglia P, Kadiu I, Rabiner E, Maguire P, Owen DR, Johnson MR. Translocator protein PET imaging in temporal lobe epilepsy: A reliable test-retest study using asymmetry index. Frontiers in Neuroimaging. 2: 1142463. PMID 37554649 DOI: 10.3389/fnimg.2023.1142463 |
0.089 |
|
2011 |
Kaminski RM, Núñez-Taltavull JF, Budziszewska B, Lasoń W, Gasior M, Zapata A, Shippenberg TS, Witkin JM. Effects of cocaine-kindling on the expression of NMDA receptors and glutamate levels in mouse brain. Neurochemical Research. 36: 146-52. PMID 20927585 DOI: 10.1007/S11064-010-0284-2 |
0.088 |
|
2021 |
Abram M, Rapacz A, Latacz G, Szulczyk B, Kalinowska-Tłuścik J, Otto-Ślusarczyk D, Struga M, Kamiński RM, Kamiński K. Asymmetric synthesis and in vivo/in vitro characterization of new hybrid anticonvulsants derived from (2,5-dioxopyrrolidin-1-yl)phenylacetamides. Bioorganic Chemistry. 109: 104751. PMID 33647745 DOI: 10.1016/j.bioorg.2021.104751 |
0.085 |
|
2011 |
Kaminski RM, Rogawski MA. 11β-Hydroxylase inhibitors protect against seizures in mice by increasing endogenous neurosteroid synthesis. Neuropharmacology. 61: 133-7. PMID 21458468 DOI: 10.1016/j.neuropharm.2011.03.019 |
0.079 |
|
2013 |
Pitkänen A, Nehlig A, Brooks-Kayal AR, Dudek FE, Friedman D, Galanopoulou AS, Jensen FE, Kaminski RM, Kapur J, Klitgaard H, Löscher W, Mody I, Schmidt D. Issues related to development of antiepileptogenic therapies. Epilepsia. 54: 35-43. PMID 23909852 DOI: 10.1111/Epi.12297 |
0.078 |
|
2016 |
Surges R, Kretschmann A, Abnaof K, van Rikxoort M, Ridder K, Fröhlich H, Danis B, Kaminski RM, Foerch P, Elger CE, Weinsberg F, Pfeifer A. Changes in serum miRNAs following generalized convulsive seizures in human mesial temporal lobe epilepsy. Biochemical and Biophysical Research Communications. PMID 27833019 DOI: 10.1016/J.Bbrc.2016.11.029 |
0.077 |
|
2017 |
Mullier B, Wolff C, Sands ZA, Ghisdal P, Muglia P, Kaminski RM, André VM. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors. Neuropharmacology. PMID 28533163 DOI: 10.1016/J.Neuropharm.2017.05.017 |
0.073 |
|
2015 |
Johnson MR, Behmoaras J, Bottolo L, Krishnan ML, Pernhorst K, Santoscoy PL, Rossetti T, Speed D, Srivastava PK, Chadeau-Hyam M, Hajji N, Dabrowska A, Rotival M, Razzaghi B, Kovac S, ... ... Kaminski RM, et al. Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus. Nature Communications. 6: 6031. PMID 25615886 DOI: 10.1038/Ncomms7031 |
0.073 |
|
2015 |
Hagy HM, Kaminski RM. Determination of foraging thresholds and effects of application on energetic carrying capacity for waterfowl. Plos One. 10: e0118349. PMID 25790255 DOI: 10.1371/journal.pone.0118349 |
0.073 |
|
2019 |
Wood M, Daniels V, Provins L, Wolff C, Kaminski RM, Gillard M. Pharmacological profile of the novel antiepileptic drug candidate padsevonil - interactions with synaptic vesicle 2 proteins and the GABAA receptor. The Journal of Pharmacology and Experimental Therapeutics. PMID 31619465 DOI: 10.1124/jpet.119.261149 |
0.072 |
|
2024 |
Bakner DL, Ringelman KM, Reynolds LA, Kaminski RM, Stephens SE, Davis JB. Wood ducks and hooded mergansers as interspecific brood parasites: An evaluation of parasitic egg survival. Ecology and Evolution. 14: e11721. PMID 38994215 DOI: 10.1002/ece3.11721 |
0.071 |
|
2013 |
Daniels V, Wood M, Leclercq K, Kaminski RM, Gillard M. Modulation of the conformational state of the SV2A protein by an allosteric mechanism as evidenced by ligand binding assays. British Journal of Pharmacology. 169: 1091-101. PMID 23530581 DOI: 10.1111/bph.12192 |
0.069 |
|
2012 |
Simonato M, Löscher W, Cole AJ, Dudek FE, Engel J, Kaminski RM, Loeb JA, Scharfman H, Staley KJ, Velíšek L, Klitgaard H. Finding a better drug for epilepsy: preclinical screening strategies and experimental trial design. Epilepsia. 53: 1860-7. PMID 22708847 DOI: 10.1111/J.1528-1167.2012.03541.X |
0.067 |
|
2008 |
Margineanu DG, Matagne A, Kaminski RM, Klitgaard H. Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in rats. Brain Research Bulletin. 77: 282-5. PMID 18722515 DOI: 10.1016/j.brainresbull.2008.07.006 |
0.066 |
|
2020 |
Auvin S, Dozières-Puyravel B, Avbersek A, Sciberras D, Collier J, Leclercq K, Mares P, Kaminski RM, Muglia P. Radiprodil, a NR2B negative allosteric modulator, from bench to bedside in infantile spasm syndrome. Annals of Clinical and Translational Neurology. PMID 32106360 DOI: 10.1002/acn3.50998 |
0.062 |
|
2023 |
Oggianu L, Garrone B, Fiorentini F, Del Bene F, Rosignoli MT, Di Giorgio FP, Kaminski RM. PK/PD analysis of trazodone and gabapentin in neuropathic pain rodent models: Translational PK-PD modeling from nonclinical to clinical development. Clinical and Translational Science. PMID 36785922 DOI: 10.1111/cts.13472 |
0.062 |
|
2016 |
Danis B, van Rikxoort M, Kretschmann A, Zhang J, Godard P, Andonovic L, Siegel F, Niehusmann P, Hanon E, Delev D, von Lehe M, Kaminski RM, Pfeifer A, Foerch P. Differential expression of miR-184 in temporal lobe epilepsy patients with and without hippocampal sclerosis - Influence on microglial function. Scientific Reports. 6: 33943. PMID 27666871 DOI: 10.1038/srep33943 |
0.061 |
|
2020 |
Niespodziany I, Ghisdal P, Mullier B, Wood M, Provins L, Kaminski RM, Wolff C. Functional characterization of the antiepileptic drug candidate, padsevonil, on GABA receptors. Epilepsia. PMID 32297665 DOI: 10.1111/epi.16497 |
0.06 |
|
2018 |
Chong SA, Balosso S, Vandenplas C, Szczesny G, Hanon E, Claes K, Van Damme X, Danis B, Van Eyll J, Wolff C, Vezzani A, Kaminski RM, Niespodziany I. Intrinsic Inflammation Is a Potential Anti-Epileptogenic Target in the Organotypic Hippocampal Slice Model. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 29464573 DOI: 10.1007/s13311-018-0607-6 |
0.06 |
|
2015 |
Johnson MR, Shkura K, Langley SR, Delahaye-Duriez A, Srivastava P, Hill WD, Rackham OJ, Davies G, Harris SE, Moreno-Moral A, Rotival M, Speed D, Petrovski S, Katz A, Hayward C, ... ... Kaminski RM, et al. Systems genetics identifies a convergent gene network for cognition and neurodevelopmental disease. Nature Neuroscience. PMID 26691832 DOI: 10.1038/nn.4205 |
0.06 |
|
2010 |
Detrait ER, Leclercq K, Löscher W, Potschka H, Niespodziany I, Hanon E, Kaminski RM, Matagne A, Lamberty Y. Brivaracetam does not alter spatial learning and memory in both normal and amygdala-kindled rats. Epilepsy Research. 91: 74-83. PMID 20678901 DOI: 10.1016/j.eplepsyres.2010.06.014 |
0.058 |
|
1983 |
Kappus KD, Monath TP, Kaminski RM, Calisher CH. Reported encephalitis associated with California serogroup virus infections in the United States, 1963-1981. Progress in Clinical and Biological Research. 123: 31-41. PMID 6867038 |
0.054 |
|
2021 |
Chase RA, DeJuilio PA, Huml JP, Johnson AP, Kaminski RM. Implementation of point-of-care blood gas testing at a large community hospital: Cost analysis, sepsis bundle compliance, and employee engagement. Canadian Journal of Respiratory Therapy : Cjrt = Revue Canadienne De La Therapie Respiratoire : Rctr. 57: 60-67. PMID 34164573 DOI: 10.29390/cjrt-2021-008 |
0.051 |
|
2006 |
Kaminski RM, Marini H, Ortinski PI, Vicini S, Rogawski MA. The pheromone androstenol (5 alpha-androst-16-en-3 alpha-ol) is a neurosteroid positive modulator of GABAA receptors. The Journal of Pharmacology and Experimental Therapeutics. 317: 694-703. PMID 16415088 DOI: 10.1124/Jpet.105.098319 |
0.05 |
|
2020 |
Horvath AA, Csernus EA, Lality S, Kaminski RM, Kamondi A. Inhibiting Epileptiform Activity in Cognitive Disorders: Possibilities for a Novel Therapeutic Approach. Frontiers in Neuroscience. 14: 557416. PMID 33177974 DOI: 10.3389/fnins.2020.557416 |
0.046 |
|
2005 |
Kaminski RM, Marini H, Kim WJ, Rogawski MA. Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia. 46: 819-27. PMID 15946323 DOI: 10.1111/j.1528-1167.2005.00705.x |
0.04 |
|
2009 |
Runyon SP, Orr M, Navarro HA, Kepler JA, Rogawski MA, Kaminski RM, Cook CE. 17beta-Nitro-5alpha-androstan-3alpha-ol and its 3beta-methyl derivative: neurosteroid analogs with potent anticonvulsant and anxiolytic activities. European Journal of Pharmacology. 617: 68-73. PMID 19577558 DOI: 10.1016/J.Ejphar.2009.06.052 |
0.039 |
|
2004 |
Oz M, Woods AS, Shippenberg T, Kaminski RM. Effects of extracellular pH on the dynorphin A inhibition of N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Synapse (New York, N.Y.). 52: 84-8. PMID 15034914 DOI: 10.1002/Syn.20009 |
0.038 |
|
2019 |
Finnema SJ, Rossano S, Naganawa M, Henry S, Gao H, Pracitto R, Maguire RP, Mercier J, Kervyn S, Nicolas JM, Klitgaard H, DeBruyn S, Otoul C, Martin P, Muglia P, ... ... Kaminski RM, et al. A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers. Epilepsia. PMID 30924924 DOI: 10.1111/epi.14701 |
0.035 |
|
2022 |
Sklepkiewicz P, Dymek BA, Mlacki M, Koralewski R, Mazur M, Nejman-Gryz P, Korur S, Zagozdzon A, Rymaszewska A, von der Thüsen JH, Siwińska AM, Güner NC, Cheda Ł, Paplinska-Goryca M, Proboszcz M, et al. Inhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis. European Journal of Pharmacology. 919: 174792. PMID 35122869 DOI: 10.1016/j.ejphar.2022.174792 |
0.015 |
|
Hide low-probability matches. |